Physicians, scientists, engineers and operators.
GenREY's leadership combines clinical depth, scientific rigour and operator pragmatism — assembled to ship real medicine, not slide decks.
Our co-founders include a CEO who architects strategy and execution across the platform, an O-1A / EB-1A Extraordinary-Ability physician-scientist with 20+ peer-reviewed PubMed publications serving as Chief Medical Officer, and a CSO bridging regenerative biology with translational science. Together they set platform direction, scientific strategy and partnership architecture.
Our scientific and medical leadership covers oncology biology, critical care and trauma surgery, reconstructive medicine, bioengineering and computational omics. Each member is an active practitioner — not an advisor in name only — bringing operational standards from real clinical and laboratory environments.
We deliberately keep the team multidisciplinary. Regenerative medicine fails when it is left to a single specialty; it succeeds when surgeons, biologists, engineers and computational scientists ship together. That cross-functional fluency is the operating system of GenREY.
Physicians, scientists, engineers and operators — one regenerative mission.
Founding & scientific leadership of GenREY Inc. — a multidisciplinary team spanning physician-scientists, regenerative biology, bioengineering, critical care, oncology, omics and translational commercialization.
U.S. physician-scientist · O-1A / EB-1A Extraordinary-Ability · 20+ peer-reviewed PubMed publications · pioneering protocols in organ regeneration and translational regenerative medicine.
Strategic execution and platform deployment lead — drives operational delivery, partnership architecture and the commercial translation engine across the GenREY platform.
Regenerative biology and translational science — leads scientific strategy across the GenREY platform, with deep expertise in cell biology and translational research.
Senior medical advisor on oncology biology and integrated pain medicine — bridging translational research with clinical practice.
Expertise in critical care and trauma surgery — guiding clinical-translation pathways and surgical-access methodologies for regenerative platforms.
Reconstructive medicine lead — translates regenerative-engineering principles into surgical reconstruction practice and patient outcomes.
Bioengineering lead — drives device architecture, micro-fluidics and delivery-system engineering across the iREY/DAMI platform.
Genomics, proteomics and AI-driven omics integration — anchors GenREY's genomic-intelligence and precision-medicine programs.
A multidisciplinary team of physicians, scientists and operators.
Want to work with us — or join us?
We engage with strategic partners, sovereign investors, and a handful of senior scientific hires per phase.